usecasehitident
Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
usecasehitident [2013/10/09 08:39] – rkiss | usecasehitident [2014/01/01 15:49] (current) – flack | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== | + | ====== |
- | [[http:// | + | [[http:// |
- | You can identify new inhibitors/ | + | You can identify new inhibitors/ |
- | **__[[usecasestrbased|Structure-based virtual screening | + | **[[usecasestrbased|Structure-based virtual screening |
- | **__[[usecaseligbased|Ligand-based virtual screening | + | **[[usecaseligbased|Ligand-based virtual screening |
+ | -- | ||
- | ====== Ligand-based virtual screening ====== | + | **[[usecases|Go back to use cases »]]** |
- | + | ||
- | Ligand-based virtual screening does not utilize the 3D structure of the target when searching for new hits. Instead, it is based on the structure of a reference ligand (endogenous ligand, known inhibitor, etc.) that binds to a target and/or exhibits some beneficial effect. In ligand-based virtual screening, compounds are typically ranked based on the similarity to the reference ligand (query). | + | |
- | + | ||
- | **__[[usecases|Go back to use cases >>]]__** | + |
usecasehitident.txt · Last modified: 2014/01/01 15:49 by flack